The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
Open accessAbstract
Extracellular vesicles (EVs) are secreted by almost all cells. They contain proteins, lipids, and nucleic acids which are delivered from the parent cells to the recipient cells. Thereby, they function as mediators of intercellular communication and molecular transfer. Recent evidences suggest that exosomes, a small subset of EVs, are involved in numerous physiological and pathological processes and play essential roles in remodeling the tumor immune microenvironment even before the occurrence and metastasis of cancer. Exosomes derived from tumor cells and host cells mediate their mutual regulation locally or remotely, thereby determining the responsiveness of cancer therapies. As such, tumor‐derived circulating exosomes are considered as noninvasive biomarkers for early detection and diagnosis of tumor. Exosome‐based therapies are also emerging as cutting‐edge and promising strategies that could be applied to suppress tumor progression or enhance anti‐tumor immunity. Herein, the current understanding of exosomes and their key roles in modulating immune responses, as well as their potential therapeutic applications are outlined. The limitations of current studies are also presented and directions for future research are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–217 of 217
Nucleic acids in exosomes: Disease markers and intercellular communication molecules
Gusachenko, O. N., Аркадьевна, З. М., & Vlassov, V. V. (2013) · Biochemistry (Moscow) · doi:10.1134/s000629791301001x · Cited by 109
ESCRT ubiquitin-binding domains function cooperatively during MVB cargo sorting
Shields, S. B., Oestreich, A. J., Winistorfer, S., Nguyen, D., Payne, J. A., Katzmann, D. J., & Piper, R. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811130 · Cited by 101
Exosomes from Cell Culture-Conditioned Medium: Isolation by Ultracentrifugation and Characterization
Purushothaman, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9133-4_19 · Cited by 100
Novel nanosensing technologies for exosome detection and profiling
Im, H., Lee, K., Weissleder, R., Lee, H., & Castro, C. M. (2017) · Lab on a Chip · doi:10.1039/c7lc00247e · Cited by 88
Analysis of Extracellular Vesicles Using Fluorescence Nanoparticle Tracking Analysis
Carnell-Morris, P., Tannetta, D., Siupa, A., Hole, P., & Dragovic, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7253-1_13 · Cited by 87
Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives
Raimondo, S., Pucci, M., Alessandro, R., & Fontana, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072286 · Cited by 79
Li, X., Liu, J.-T., Fan, L.-L., Liu, Y., Cheng, L., Wang, F., Yu, H., Gao, J., Wei, W., Wang, H., et al. (2016) · OncoTarget · doi:10.18632/oncotarget.8358 · Cited by 76
Prostasomes as a source of diagnostic biomarkers for prostate cancer
Zijlstra, C., & Stoorvogel, W. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81128 · Cited by 75
Xu, Y., Liu, Y., Yang, C., Kang, L., Wang, M., Hu, J., He, H., Song, W., & Tang, H. (2016) · Immunology · doi:10.1111/imm.12630 · Cited by 75
Role of Lymphocyte Subsets in the Immune Response to Primary B Cell–Derived Exosomes
Saunderson, S. C., & McLellan, A. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601537 · Cited by 68
Rab27A regulates exosome secretion from lung adenocarcinoma cells A549: involvement of EPI 64
Li, W., Hu, Y., Jiang, T., Han, Y., Han, G., Chen, J., & Li, X. (2014) · Apmis · doi:10.1111/apm.12261 · Cited by 67
Chang, D. K.-F., Grimmond, S. M., & Biankin, A. V. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.001 · Cited by 65
Nazimek, K., Ptak, W., Nowak, B., Ptak, M., Askenase, P. W., & Bryniarski, K. (2015) · Immunology · doi:10.1111/imm.12466 · Cited by 57
Membrane Protein Targeting to the MVB/Lysosome
Davies, B. A., Lee, J. R. E., Oestreich, A. J., & Katzmann, D. J. (2009) · Chemical Reviews · doi:10.1021/cr800473s · Cited by 56
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
Jin, S., Yang, Z., Hao, X., Tang, W., Ma, W., & Zong, H. (2020) · Biomarker Research · doi:10.1186/s40364-020-00201-8 · Cited by 51
Rodriguez, N. F., Kenwright, D. A., Chung, P., Harrison, A. W., Stefani, F., Waigh, T. A., Allan, V., & Woodman, P. G. (2015) · Journal of Cell Science · doi:10.1242/jcs.161786 · Cited by 28
Wei, N., Zhang, H., Wang, J., Wang, S., Lv, W., Luo, L., & Xu, Z. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00405 · Cited by 15
Cited by
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Exosome-based immunotherapy: a promising approach for cancer treatment
Xu, Z., Zeng, S., Gong, Z., & Yan, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01278-3 · Cited by 482
Xu, Z., Chen, Y., Ma, L., Chen, Y., Liu, J., Guo, Y., Yu, T., Zhang, L., Zhu, L., & Shu, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.046 · Cited by 319
Self-citation
Metadata
- Authors
- Xie, F., Zhou, X., Fang, M., Li, H., Su, P., Tu, Y., Zhang, L., & Zhou, F.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-10-23
- Volume
- 6
- Issue
- 24
- Pages
- 1901779-1901779
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W2982091811
- Cited by
- 327
- References
- 217
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.